1 – 36 of 36
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Ever Smoking is Not Associated with Performed Spirometry while Occupational Exposure and Respiratory Symptoms are
(
- Contribution to journal › Article
- 2021
-
Mark
Wtreatment of copd with long-acting bronchodilators : Association between early and longer-term clinically important improvement
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article
-
Mark
Dual bronchodilator therapy as first-line treatment in maintenance-naïve patients with symptomatic copd : A pre-specified analysis of the emax trial
(
- Contribution to journal › Article
-
Mark
How to assess breathlessness in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Non-exacerbating patients with COPD from a UK perspective using the galaxy model
(
- Contribution to journal › Article
-
Mark
Advanced dental cleaning is associated with reduced risk of copd exacerbations – a randomized controlled trial
(
- Contribution to journal › Article
- 2020
-
Mark
Decreased risk of ischemic heart disease in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population
(
- Contribution to journal › Article
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
(
- Contribution to journal › Article
-
Mark
Reduced variability of endurance time in new protocols for exercise tests in COPD
(
- Contribution to journal › Article
- 2019
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article
-
Mark
Patient registries for home oxygen research and evaluation
(
- Contribution to journal › Article
- 2018
-
Mark
Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward
(
- Contribution to journal › Scientific review
-
Mark
The Efficiency Index (EFFi), based on volumetric capnography, may allow for simple diagnosis and grading of COPD
(
- Contribution to journal › Article
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients
(
- Contribution to journal › Article
- 2017
-
Mark
Risk of cancer after lung transplantation for COPD
(
- Contribution to journal › Article
-
Mark
Burn injury during long-term oxygen therapy in Denmark and Sweden : The potential role of smoking
(
- Contribution to journal › Article
-
Mark
The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
(
- Contribution to journal › Article
-
Mark
Inflammation and chronic colonization of Haemophilus influenzae in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography
(
- Contribution to journal › Article
-
Mark
Prediction models for exacerbations in different COPD patient populations : Comparing results of five large data sources
(
- Contribution to journal › Article
-
Mark
A nationwide structure for valid Long-Term oxygen therapy : 29-Year prospective data in Sweden
(
- Contribution to journal › Article
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
(
- Contribution to journal › Article
-
Mark
Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS pilot study
(
- Contribution to journal › Article
-
Mark
Authors’ reply
(
- Contribution to journal › Letter
-
Mark
Risk factors for developing hypoxic respiratory failure in COPD
(
- Contribution to journal › Article
-
Mark
Identifying the heterogeneity of COPD by V/P SPECT : A new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease
(
- Contribution to journal › Article
-
Mark
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
(
- Contribution to journal › Article
-
Mark
Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status
(
- Contribution to journal › Article
-
Mark
Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha I-antitrypsin deficiency
(
- Contribution to journal › Article
- 2016
-
Mark
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden
(
- Contribution to journal › Article
-
Mark
Persistent disabling breathlessness in chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Vital capacity and COPD : The Swedish CArdioPulmonary bioImage Study (SCAPIS)
(
- Contribution to journal › Article
-
Mark
Bronchodilator response of advanced lung function parameters depending on COPD severity
(
- Contribution to journal › Article
-
Mark
Author’s reply
(
- Contribution to journal › Letter
-
Mark
Prescription of opioids for breathlessness in end-stage COPD : A national population-based study
(
- Contribution to journal › Article